[Suicide in prison: Epidemiology and prevention].

Le suicide en prison : épidémiologie et dispositifs de prévention.

Journal

Presse medicale (Paris, France : 1983)
ISSN: 2213-0276
Titre abrégé: Presse Med
Pays: France
ID NLM: 8302490

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 21 06 2018
revised: 20 09 2018
accepted: 07 11 2018
pubmed: 28 1 2019
medline: 27 2 2019
entrez: 28 1 2019
Statut: ppublish

Résumé

Suicide is one of the most important causes of death in prison around the world. In France, suicide rate for prisoners is 18.5 suicides per 10,000 inmates: seven times more common than in the general population. Among the risk factors identified in the literature, those most strongly associated with suicide in prison are physical isolation in custody, psychiatric history and history of suicide attempts. The prevention of suicide in prison involves several measures including treatment of psychiatric disorders, improvement of living conditions in custody, social support of prisoners and use of specific tools and programs by prison supervisors. No program for prevention of suicidal recurrence has ever been implemented. We propose to adapt « VigilanS », a program already applied in the general population, to the prison population.

Identifiants

pubmed: 30685227
pii: S0755-4982(18)30455-X
doi: 10.1016/j.lpm.2018.11.009
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

46-54

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Marion Eck (M)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France. Electronic address: eckmarion@yahoo.fr.

Tatiana Scouflaire (T)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France.

Christophe Debien (C)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France.

Ali Amad (A)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France; Univ. Lille, CNRS UMR 9193, laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), 59000 Lille, France.

Olivier Sannier (O)

Médecin conseil, Ecopolis, 53, avenue de l'Europe, 80000 Amiens, France.

Christine Chan Chee (C)

Santé publique France, direction des maladies non transmissibles et traumatismes, 94415 Saint Maurice, France.

Pierre Thomas (P)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France; Univ. Lille, CNRS UMR 9193, laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), 59000 Lille, France.

Guillaume Vaiva (G)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France; Univ. Lille, CNRS UMR 9193, laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), 59000 Lille, France.

Thomas Fovet (T)

CHU Lille, Pôle de Psychiatrie, unité CURE, 59000 Lille, France; Univ. Lille, CNRS UMR 9193, laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), 59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH